A Randomized, Double Blind, Multicenter, Parallel Controlled, Phase III Trial to compare the effect and safety of Allisartan Isoproxil 240mg and losartan potassium 50mg in Patients with hypertension.
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Allisartan (Primary) ; Losartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 21 May 2012 Actual end date changed from Dec 2009 to Mar 2010 as reported by Chinese Clinical Trial Register record.
- 21 May 2012 Actual initiation date changed from Jun 2009 to Mar 2009 as reported by Chinese Clinical Trial Register record.
- 09 Jun 2010 New trial record